The cell biology of the intestinal epithelium and its relation to inflammatory bowel disease

Abrams, 1963, Cellular renewal and mucosal morphology in experimental enteritis. Infection with salmonella typhimurium in the mouse, Laboratory Investigation: A Journal of Technical Methods and Pathology, 12, 1241 Abreu, 2002, TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells, Journal of Biological Chemistry, 277, 20431, 10.1074/jbc.M110333200 Al-Lahham, 2010, Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms, Biochimica Et Biophysica Acta, 1801, 1175, 10.1016/j.bbalip.2010.07.007 Alonso, 2008, Maladaptive intestinal epithelial responses to life stress may predispose healthy women to gut mucosal inflammation, Gastroenterology, 135, 163, 10.1053/j.gastro.2008.03.036 Amieva, 2002, Helicobacter pylori enter and survive within multivesicular vacuoles of epithelial cells, Cellular Microbiology, 4, 677, 10.1046/j.1462-5822.2002.00222.x Andersen, 2011, Polymorphisms in NF-kappaB, PXR, LXR, PPARgamma and risk of inflammatory bowel disease, World Journal of Gastroenterology, 17, 197, 10.3748/wjg.v17.i2.197 Anderson, 2011, Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47, Nature Genetics, 43, 246, 10.1038/ng.764 Ardite, 1998, Effects of steroid treatment on activation of nuclear factor kappaB in patients with inflammatory bowel disease, British Journal of Pharmacology, 124, 431, 10.1038/sj.bjp.0701887 Baan, 2012, 5-aminosalicylic acid inhibits cell cycle progression in a phospholipase D dependent manner in colorectal cancer, Gut, 61, 1708, 10.1136/gutjnl-2011-301626 Baars, 2012, Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey, Journal of Gastroenterology, 10.1007/s00535-012-0603-2 Barrett, 2008, Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease, Nature Genetics, 40, 955, 10.1038/ng.175 Bibiloni, 2006, The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients, Journal of Medical Microbiology, 55, 1141, 10.1099/jmm.0.46498-0 Bijvelds, 2009, Activation of intestinal Cl-secretion by lubiprostone requires the cystic fibrosis transmembrane conductance regulator, Gastroenterology, 137, 976, 10.1053/j.gastro.2009.05.037 Bleuming, 2004, Homeostasis of the adult colonic epithelium: a role for morphogens, Scandinavian Journal of Gastroenterology, 39, 93, 10.1080/00365520310005451 Blokzijl, 2007, Decreased P-glycoprotein (P-gp/MDR1) expression in inflamed human intestinal epithelium is independent of PXR protein levels, Inflammatory Bowel Diseases, 13, 710, 10.1002/ibd.20088 Bonizzi, 2004, The two NF-kappaB activation pathways and their role in innate and adaptive immunity, Trends in Immunology, 25, 280, 10.1016/j.it.2004.03.008 Cadwell, 2008, A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells, Nature, 456, 259, 10.1038/nature07416 Cadwell, 2010, Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine, Cell, 141, 1135, 10.1016/j.cell.2010.05.009 Campieri, 2003, Oral beclometasone dipropionate in the treatment of extensive and left-sided active ulcerative colitis: a multicentre randomised study, Alimentary Pharmacology & Therapeutics, 17, 1471, 10.1046/j.1365-2036.2003.01609.x Cario, 2000, Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease, Infection and Immunity, 68, 7010, 10.1128/IAI.68.12.7010-7017.2000 Colombel, 2011, Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis, Gastroenterology, 141, 1194, 10.1053/j.gastro.2011.06.054 Comalada, 2006, Impaired innate immunity in Crohn's disease, Trends in Molecular Medicine, 12, 397, 10.1016/j.molmed.2006.07.005 Consortium, 2009, Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region, Nature Genetics, 41, 1330, 10.1038/ng.483 Corridoni, 2012, Probiotic bacteria regulate intestinal epithelial permeability in experimental ileitis by a TNF-dependent mechanism, PloS One, 7, e42067, 10.1371/journal.pone.0042067 Cosnes, 1996, Effects of cigarette smoking on the long-term course of Crohn's disease, Gastroenterology, 110, 424, 10.1053/gast.1996.v110.pm8566589 Cucchiara, 2012, Interactions between intestinal microbiota and innate immune system in pediatric inflammatory bowel disease, Journal of Clinical Gastroenterology, 46, S64, 10.1097/MCG.0b013e31826a857f D’Auria, 2012, Systems analysis of the transcriptional response of human ileocecal epithelial cells to Clostridium difficile toxins and effects on cell cycle control, BMC Systems Biology, 6, 2, 10.1186/1752-0509-6-2 Dallegri, 1990, Cytoprotection against neutrophil derived hypochlorous acid: a potential mechanism for the therapeutic action of 5-aminosalicylic acid in ulcerative colitis, Gut, 31, 184, 10.1136/gut.31.2.184 Das, 2001, MICA engagement by human Vgamma2Vdelta2 T cells enhances their antigen-dependent effector function, Immunity, 15, 83, 10.1016/S1074-7613(01)00168-6 De Filippo, 2010, Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa, Proceedings of the National Academy of Sciences of the United States of America, 107, 14691, 10.1073/pnas.1005963107 Desreumaux, 2001, Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies, The Journal of Experimental Medicine, 193, 827, 10.1084/jem.193.7.827 Deuring, 2012, Absence of ABCG2-mediated mucosal detoxification in patients with active inflammatory bowel disease is due to impeded protein folding, The Biochemical Journal, 441, 87, 10.1042/BJ20111281 Deuring, 2011, Impeded protein folding and function in active inflammatory bowel disease, Biochemical Society Transactions, 39, 1107, 10.1042/BST0391107 Deuring JJ, Peppelenbosch MP, Kuipers EJ, de Haar C, van der Woude CJ, 2012. Genomic ATG16L1 risk allele-restricted Paneth cell ER stress in quiescent Crohn's disease, in preparation. Devkota, 2012, Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10−/− mice, Nature, 487, 104, 10.1038/nature11225 Dignass, 2010, The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: current management, Journal of Crohn's & Colitis, 4, 28, 10.1016/j.crohns.2009.12.002 Dominguez-Bello, 2011, Development of the human gastrointestinal microbiota and insights from high-throughput sequencing, Gastroenterology, 140, 1713, 10.1053/j.gastro.2011.02.011 Donohoe, 2011, The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon, Cell Metabolism, 13, 517, 10.1016/j.cmet.2011.02.018 Dring, 2006, The pregnane X receptor locus is associated with susceptibility to inflammatory bowel disease, Gastroenterology, 130, 341, 10.1053/j.gastro.2005.12.008 Eaden, 2001, The risk of colorectal cancer in ulcerative colitis: a meta-analysis, Gut, 48, 526, 10.1136/gut.48.4.526 Egan, 1999, Inhibition of interleukin-1-stimulated NF-kappaB RelA/p65 phosphorylation by mesalamine is accompanied by decreased transcriptional activity, The Journal of Biological Chemistry, 274, 26448, 10.1074/jbc.274.37.26448 Fajas, 1997, The organization, promoter analysis, and expression of the human PPARgamma gene, The Journal of Biological Chemistry, 272, 18779, 10.1074/jbc.272.30.18779 Franke, 2010, Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci, Nature Genetics, 42, 1118, 10.1038/ng.717 Gadaleta, 2011, Activation of bile salt nuclear receptor FXR is repressed by pro-inflammatory cytokines activating NF-kappaB signaling in the intestine, Biochimica Et Biophysica Acta, 10.1016/j.bbadis.2011.04.005 Gadaleta, 2011, Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease, Gut, 10.1136/gut.2010.212159 Goke, 2002, Differential glucocorticoid effects on repair mechanisms and NF-kappaB activity in the intestinal epithelium, Regulatory Peptides, 105, 203, 10.1016/S0167-0115(02)00023-X Gordon, 1971, The gnotobiotic animal as a tool in the study of host microbial relationships, Bacteriological Reviews, 35, 390, 10.1128/MMBR.35.4.390-429.1971 Goretsky, 2012, p53 mediates TNF-induced epithelial cell apoptosis in IBD, The American Journal of Pathology, 10.1016/j.ajpath.2012.06.016 Groh, 1996, Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium, Proceedings of the National Academy of Sciences of the United States of America, 93, 12445, 10.1073/pnas.93.22.12445 Groh, 2001, Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells, Nature Immunology, 2, 255, 10.1038/85321 Groot, 2000, Stress-induced decrease of the intestinal barrier function. The role of muscarinic receptor activation, Annals of the New York Academy of Sciences, 915, 237, 10.1111/j.1749-6632.2000.tb05247.x Hamady, 2009, Microbial community profiling for human microbiome projects: tools, techniques, and challenges, Genome Research, 19, 1141, 10.1101/gr.085464.108 Hanauer, 2002, Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial, Lancet, 359, 1541, 10.1016/S0140-6736(02)08512-4 Hardwick, 2004, DNA array analysis of the effects of aspirin on colon cancer cells: involvement of Rac1, Carcinogenesis, 25, 1293, 10.1093/carcin/bgh118 Hart, 2002, Review article: mechanisms of initiation and perpetuation of gut inflammation by stress, Alimentary Pharmacology & Therapeutics, 16, 2017, 10.1046/j.1365-2036.2002.01359.x Hase, 2009, Uptake through glycoprotein 2 of FimH(+) bacteria by M cells initiates mucosal immune response, Nature, 462, 226, 10.1038/nature08529 Hebuterne, 2012, Endoscopic improvement of mucosal lesions in patients with moderate to severe ileocolonic Crohn's disease following treatment with certolizumab pegol, Gut Hershberg, 1998, Highly polarized HLA class II antigen processing and presentation by human intestinal epithelial cells, The Journal of Clinical Investigation, 102, 792, 10.1172/JCI3201 Hershberg, 1997, Intestinal epithelial cells use two distinct pathways for HLA class II antigen processing, The Journal of Clinical Investigation, 100, 204, 10.1172/JCI119514 Higuchi, 2012, A prospective study of cigarette smoking and the risk of inflammatory bowel disease in women, The American Journal of Gastroenterology, 107, 1399, 10.1038/ajg.2012.196 Hugot, 2001, Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease, Nature, 411, 599, 10.1038/35079107 Isozaki, 2006, Anti-tryptase treatment using nafamostat mesilate has a therapeutic effect on experimental colitis, Scandinavian Journal of Gastroenterology, 41, 944, 10.1080/00365520500529470 Jewell, 1974, Azathioprine in ulcerative colitis: final report on controlled therapeutic trial, British Medical Journal, 4, 627, 10.1136/bmj.4.5945.627 Johansson, 2011, Microbiology keeping bacteria at a distance, Science, 334, 182, 10.1126/science.1213909 Jostins, 2012, Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease, Nature, 491, 119, 10.1038/nature11582 Karin, 2005, NF-kappaB: linking inflammation and immunity to cancer development and progression, Nature Reviews Immunology, 5, 749, 10.1038/nri1703 Kaser, 2008, XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease, Cell, 134, 743, 10.1016/j.cell.2008.07.021 Koenig, 2011, Succession of microbial consortia in the developing infant gut microbiome, Proceedings of the National Academy of Sciences of the United States of America, 108, 4578, 10.1073/pnas.1000081107 Langmann, 2004, Loss of detoxification in inflammatory bowel disease: dysregulation of pregnane X receptor target genes, Gastroenterology, 127, 26, 10.1053/j.gastro.2004.04.019 Laukoetter, 2006, Regulation of the intestinal epithelial barrier by the apical junctional complex, Current Opinion in Gastroenterology, 22, 85, 10.1097/01.mog.0000203864.48255.4f Lichtenstein, 2010, Importance of mucosal healing in ulcerative colitis, Inflammatory Bowel Diseases, 16, 338, 10.1002/ibd.20997 Lionetti, 2005, Enteral nutrition and microflora in pediatric Crohn's disease, JPEN Journal of Parenteral and Enteral Nutrition, 29, S173, 10.1177/01486071050290S4S173 Maltzman, 2003, Azathioprine: old drug, new actions, The Journal of Clinical Investigation, 111, 1122, 10.1172/JCI200318384 Manichanh, 2012, The gut microbiota in IBD, Nature Reviews Gastroenterology & Hepatology, 9, 599, 10.1038/nrgastro.2012.152 Mantzaris, 2009, Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn's disease, Inflammatory Bowel Diseases, 15, 375, 10.1002/ibd.20777 Marini, 2003, TNF-alpha neutralization ameliorates the severity of murine Crohn's-like ileitis by abrogation of intestinal epithelial cell apoptosis, Proceedings of the National Academy of Sciences of the United States of America, 100, 8366, 10.1073/pnas.1432897100 Marshall, 1997, Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis, Gut, 40, 775, 10.1136/gut.40.6.775 Matthews, 2012, Short-chain fatty acids induce apoptosis in colon cancer cells associated with changes to intracellular redox state and glucose metabolism, Chemotherapy, 58, 102, 10.1159/000335672 McDole, 2012, Goblet cells deliver luminal antigen to CD103+ dendritic cells in the small intestine, Nature, 483, 345, 10.1038/nature10863 McKay, 1999, Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways, Endocrine Reviews, 20, 435 Mitsuyama, 2008, Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease, Expert Opinion on Therapeutic Targets, 12, 301, 10.1517/14728222.12.3.301 Muegge, 2011, Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans, Science, 332, 970, 10.1126/science.1198719 Murakami, 2010, Efficacy of azathioprine in mild or moderate relapse in Crohn's disease: clinical and endoscopic evaluation, Digestive Endoscopy: Official Journal of the Japan Gastroenterological Endoscopy Society, 22, 25, 10.1111/j.1443-1661.2009.00914.x Nenci, 2007, Epithelial NEMO links innate immunity to chronic intestinal inflammation, Nature, 446, 557, 10.1038/nature05698 Neurath, 2012, Mucosal healing in inflammatory bowel diseases: a systematic review, Gut, 61, 1619, 10.1136/gutjnl-2012-302830 Nielsen, 2009, Influence of smoking on colonic gene expression profile in Crohn's disease, PloS One, 4, e6210, 10.1371/journal.pone.0006210 Nijmeijer, 2011, Farnesoid X receptor (FXR) activation and FXR genetic variation in inflammatory bowel disease, PLoS One, 6, e23745, 10.1371/journal.pone.0023745 Ogura, 2001, A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease, Nature, 411, 603, 10.1038/35079114 Olaison, 1990, Glucocorticoid treatment in ileal Crohn's disease: relief of symptoms but not of endoscopically viewed inflammation, Gut, 31, 325, 10.1136/gut.31.3.325 Otte, 2004, Mechanisms of cross hyporesponsiveness to toll-like receptor bacterial ligands in intestinal epithelial cells, Gastroenterology, 126, 1054, 10.1053/j.gastro.2004.01.007 Park, 2003, Clonal expansion of double-positive intraepithelial lymphocytes by MHC class I-related chain A expressed in mouse small intestinal epithelium, Journal of Immunology, 171, 4131, 10.4049/jimmunol.171.8.4131 Pastorelli, 2010, Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis, Proceedings of the National Academy of Sciences of the United States of America, 107, 8017, 10.1073/pnas.0912678107 Patel, 2002, Potato glycoalkaloids adversely affect intestinal permeability and aggravate inflammatory bowel disease, Inflammatory Bowel Diseases, 8, 340, 10.1097/00054725-200209000-00005 Patterson, 2012, Health implications of high dietary omega-6 polyunsaturated Fatty acids, Journal of Nutrition and Metabolism., 2012, 539426, 10.1155/2012/539426 Payne, 2004, Mast cell tryptase: a review of its physiology and clinical significance, Anaesthesia, 59, 695, 10.1111/j.1365-2044.2004.03757.x Pellicoro, 2007, Review article: the function and regulation of proteins involved in bile salt biosynthesis and transport, Alimentary Pharmacology and Therapeutics, 26, 149, 10.1111/j.1365-2036.2007.03522.x Perminow, 2010, Defective paneth cell-mediated host defense in pediatric ileal Crohn's disease, American Journal of Gastroenterology, 105, 452, 10.1038/ajg.2009.643 Pineton de Chambrun, 2010, Clinical implications of mucosal healing for the management of IBD, Nature Reviews Gastroenterology & Hepatology, 7, 15, 10.1038/nrgastro.2009.203 Prindiville, 2004, Ribosomal DNA sequence analysis of mucosa-associated bacteria in Crohn's disease, Inflammatory Bowel Diseases, 10, 824, 10.1097/00054725-200411000-00017 Reif, 1997, Pre-illness dietary factors in inflammatory bowel disease, Gut, 40, 754, 10.1136/gut.40.6.754 Reinisch, 2012, Long-term infliximab maintenance therapy for ulcerative colitis: the ACT-1 and -2 extension studies, Inflammatory Bowel Diseases, 18, 201, 10.1002/ibd.21697 Rescigno, 2008, The pathogenic role of intestinal flora in IBD and colon cancer, Current Drug Targets, 9, 395, 10.2174/138945008784221125 Rieder, 2012, Results of the 2nd scientific workshop of the ECCO (III): basic mechanisms of intestinal healing, Journal of Crohn's & Colitis, 6, 373, 10.1016/j.crohns.2011.11.009 Rigoli, 2008, Clinical significance of NOD2/CARD15 and Toll-like receptor 4 gene single nucleotide polymorphisms in inflammatory bowel disease, World Journal of Gastroenterology, 14, 4454, 10.3748/wjg.14.4454 Ritsema, 2003, Fructans: beneficial for plants and humans, Current Opinion in Plant Biology, 6, 223, 10.1016/S1369-5266(03)00034-7 Rizzello, 2002, Oral beclometasone dipropionate in the treatment of active ulcerative colitis: a double-blind placebo-controlled study, Alimentary Pharmacology & Therapeutics, 16, 1109, 10.1046/j.1365-2036.2002.01298.x Rutgeerts, 2005, Infliximab for induction and maintenance therapy for ulcerative colitis, The New England Journal of Medicine, 353, 2462, 10.1056/NEJMoa050516 Rutgeerts, 2012, Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial, Gastroenterology, 142, 1102, 10.1053/j.gastro.2012.01.035 Ruthig, 1999, Both (n-3) and (n-6) fatty acids stimulate wound healing in the rat intestinal epithelial cell line, IEC-6, The Journal of Nutrition, 129, 1791, 10.1093/jn/129.10.1791 Salzman, 2007, Paneth cells, defensins, and the commensal microbiota: a hypothesis on intimate interplay at the intestinal mucosa, Seminars in Immunology, 19, 70, 10.1016/j.smim.2007.04.002 Samba-Louaka, 2009, The enteropathogenic Escherichia coli effector Cif induces delayed apoptosis in epithelial cells, Infection and Immunity, 77, 5471, 10.1128/IAI.00860-09 Sandle, 1998, Salt and water absorption in the human colon: a modern appraisal, Gut, 43, 294, 10.1136/gut.43.2.294 Sandoval, 1997, Peroxynitrite-induced apoptosis in human intestinal epithelial cells is attenuated by mesalamine, Gastroenterology, 113, 1480, 10.1053/gast.1997.v113.pm9352850 Santos, 2001, Role of mast cells in chronic stress induced colonic epithelial barrier dysfunction in the rat, Gut, 48, 630, 10.1136/gut.48.5.630 Sartor, 2004, Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics, Gastroenterology, 126, 1620, 10.1053/j.gastro.2004.03.024 Sato, 2010, Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts, Nature Schreiber, 1998, Activation of nuclear factor kappa B inflammatory bowel disease, Gut, 42, 477, 10.1136/gut.42.4.477 Sen, 1986, Multiple nuclear factors interact with the immunoglobulin enhancer sequences, Cell, 46, 705, 10.1016/0092-8674(86)90346-6 Senftleben, 2001, Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway, Science, 293, 1495, 10.1126/science.1062677 Shah, 2007, Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-kappaB target gene expression, American Journal of Physiology. Gastrointestinal and Liver Physiology, 292, G1114, 10.1152/ajpgi.00528.2006 Shanahan, 2011, The colonic microflora and probiotic therapy in health and disease, Current Opinion in Gastroenterology, 27, 61, 10.1097/MOG.0b013e328340076f Shibolet, 2007, TLRs in the Gut. IV. Negative regulation of Toll-like receptors and intestinal homeostasis: addition by subtraction, American Journal of Physiology. Gastrointestinal and Liver Physiology, 292, G1469, 10.1152/ajpgi.00531.2006 Sidoroff, 2011, Glucocorticoid sensitivity in inflammatory bowel disease, Annals of Medicine, 44, 578, 10.3109/07853890.2011.590521 Simopoulos, 2006, Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases, Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 60, 502, 10.1016/j.biopha.2006.07.080 Sonnenberg, 1988, Geographic and temporal variations of sugar and margarine consumption in relation to Crohn's disease, Digestion, 41, 161, 10.1159/000199769 Stanislawowski, 2009, Decreased toll-like receptor-5 (TLR-5) expression in the mucosa of ulcerative colitis patients, Journal of Physiology and Pharmacology, 60, 71 Sullivan, 2009, Downregulation of sodium transporters and NHERF proteins in IBD patients and mouse colitis models: potential contributors to IBD-associated diarrhea, Inflammatory Bowel Diseases, 15, 261, 10.1002/ibd.20743 Sun, 2011, Host genetic susceptibility, dysbiosis, and viral triggers in inflammatory bowel disease, Current Opinion in Gastroenterology, 27, 321, 10.1097/MOG.0b013e32834661b4 Taipalensuu, 2001, Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers, The Journal of Pharmacology and Experimental Therapeutics, 299, 164 Thachil, 2012, Abnormal activation of autophagy-induced crinophagy in paneth cells from patients with Crohn's disease, Gastroenterology, 142, 1097, 10.1053/j.gastro.2012.01.031 Thompson, 1971, Gastrointestinal structure and function in germ-free or gnotobiotic animals, Gut, 12, 230, 10.1136/gut.12.3.230 Tiede, 2003, CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes, The Journal of Clinical Investigation, 111, 1133, 10.1172/JCI16432 Tighe, 2011, Nutrition and inflammatory bowel disease: primary or adjuvant therapy, Current Opinion in Clinical Nutrition and Metabolic Care, 14, 491, 10.1097/MCO.0b013e328349eb4d Travassos, 2010, Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry, Nature Immunology, 11, 55, 10.1038/ni.1823 Travis, 2008, European evidence-based Consensus on the management of ulcerative colitis: current management, Journal of Crohn's & Colitis, 2, 24, 10.1016/j.crohns.2007.11.002 Turjman, 1981, Nature of tissue-bound lithocholic acid and its implications in the role of bile acids in carcinogenesis, Cancer Research, 41, 3761 Turner, 2009, Intestinal mucosal barrier function in health and disease, Nature Reviews Immunology, 9, 799, 10.1038/nri2653 Urquhart, 2007, Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs, Journal of Clinical Pharmacology, 47, 566, 10.1177/0091270007299930 Urquhart, 2008, Breast cancer resistance protein (ABCG2) and drug disposition: intestinal expression, polymorphisms and sulfasalazine as an in vivo probe, Physiological Genomics, 18, 439 Vamadevan, 2009, Regulation of Toll-like receptor 4-associated MD-2 in intestinal epithelial cells: a comprehensive analysis, Innate Immunity, 16, 93, 10.1177/1753425909339231 van der Heide, 2011, Effects of active and passive smoking on Crohn's disease and ulcerative colitis in a cohort from a regional hospital, European Journal of Gastroenterology & Hepatology, 23, 255, 10.1097/MEG.0b013e3283435233 van der Zanden, 2009, Vagus nerve activity augments intestinal macrophage phagocytosis via nicotinic acetylcholine receptor alpha4beta2, Gastroenterology, 137, 1029, 10.1053/j.gastro.2009.04.057 van Passel, 2011, The genome of Akkermansia muciniphila, a dedicated intestinal mucin degrader, and its use in exploring intestinal metagenomes, PloS One, 6, e16876, 10.1371/journal.pone.0016876 Vandenbroucke, 2004, Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice, Gastroenterology, 127, 502, 10.1053/j.gastro.2004.05.020 Vora, 2004, Beta-defensin-2 expression is regulated by TLR signaling in intestinal epithelial cells, Journal of Immunology, 173, 5398, 10.4049/jimmunol.173.9.5398 Willson, 2002, CAR and drug metabolism, Nature Reviews Drug Discovery, 1, 259, 10.1038/nrd753 Xu, 2005, Induction of phase I, II and III drug metabolism/transport by xenobiotics, Archives of Pharmacal Research, 28, 249, 10.1007/BF02977789 Yuvaraj, 2007, Transgenic probiotica as drug delivery systems: the golden bullet, Expert Opinion on Drug Delivery, 4, 1, 10.1517/17425247.4.1.1 Zhou, 2006, Mutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammation, Journal of Clinical Investigation, 116, 2280, 10.1172/JCI26283